Evidence map›Paper›PMID 31867777›Full record

ArticleThe EMBO journal2020

NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor.

Laura Novellasdemunt, Anna Kucharska, Cara Jamieson, Maria Prange-Barczynska, Anna Baulies, Pedro Antas, Jelte van der Vaart, Helmuth Gehart, Madelon M Maurice, Vivian Sw Li

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Lgr6Genes & diseases · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Laura NovellasdemuntStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK.
Anna KucharskaStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK.
Cara JamiesonOncode Institute and Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Maria Prange-BarczynskaStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK.
Anna BauliesStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK.
Pedro AntasStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK.
Jelte van der VaartHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC) Utrecht, Utrecht, The Netherlands.
Helmuth GehartHubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Centre (UMC) Utrecht, Utrecht, The Netherlands.
Madelon M MauriceOncode Institute and Department of Cell Biology, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
Vivian Sw LiStem Cell and Cancer Biology Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0003-2041-0085
The Francis Crick Institute · GBRoyal Netherlands Academy of Arts and Sciences · NLUniversity Medical Center Utrecht · NL

Funding

European Union's Horizon 2020 Research and Innovation Programme 668294Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) 91815604Wellcome Trust FC001105ZonMw (Netherlands Organisation for Health Research and Development) 91218050
6 · The paper itself

Abstract

The intestinal stem cell (ISC) marker LGR5 is a receptor for R-spondin (RSPO) that functions to potentiate Wnt signalling in the proliferating crypt. It has been recently shown that Wnt plays a priming role for ISC self-renewal by inducing RSPO receptor LGR5 expression. Despite its pivotal role in homeostasis, regeneration and cancer, little is known about the post-translational regulation of LGR5. Here, we show that the HECT-domain E3 ligases NEDD4 and NEDD4L are expressed in the crypt stem cell regions and regulate ISC priming by degrading LGR receptors. Loss of Nedd4 and Nedd4l enhances ISC proliferation, increases sensitivity to RSPO stimulation and accelerates tumour development in Apc

Indexed as

AdenomaAnimalsCell Line, TumorCell ProliferationFemaleHCT116 CellsHEK293 CellsHumansIntestinesMaleMiceNedd4 Ubiquitin Protein LigasesOrganoidsProtein Processing, Post-TranslationalProteolysisReceptors, G-Protein-CoupledLGR5 protein, humanNedd4L protein, humanNedd4 protein, humanNedd4 Ubiquitin Protein LigasesReceptors, G-Protein-Coupledcolorectal cancerintestinal stem cellLgr5NEDD4Wnt

Identifiers

PMID31867777
PMCPMC6996568
OpenAlexW2996204530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.